Home 2023
Yearly Archives: 2023
Understanding Immunity to SARS-CoV-2 in Infants and Young Children
Infants and young children are born with immune systems that differ significantly from those of adults. These immune systems undergo profound maturation during the...
Personality Disorders and Their Impact on NAFLD Management
Non-alcoholic fatty liver disease (NAFLD) is a prevalent and significant chronic liver condition that has garnered increasing attention in recent years.
This article aims...
The Complex Relationship Between Aging, Hearing Loss, and Cognitive Decline: Implications for Speech Recognition...
Aging is an inevitable part of the human experience, marked by a multitude of physical, cognitive, and psychological changes. Two significant facets of aging...
Exploring the Complex Relationship Between Seizures, Apnea, and Sudden Unexpected Death in Epilepsy (SUDEP)
Sudden unexpected death in epilepsy (SUDEP) remains a perplexing and tragic phenomenon, accounting for a significant proportion of deaths in individuals with medically refractory...
Le catechine del tè e i loro derivati inattivano le sottovarianti Omicron di SARS-CoV-2
L’emergere del ceppo B.1.1.529 della sindrome respiratoria acuta grave coronavirus 2 (SARS-CoV-2) in Sud Africa nel novembre 2021, successivamente designato come variante Omicron dall’Organizzazione...
Tea Catechins and Their Derivatives Inactivate Omicron Subvariants of SARS-CoV-2
The emergence of the B.1.1.529 lineage of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in South Africa in November 2021, later designated as...
Red Blood Cell Morphology in Severe COVID-19: Insights from Low-Voltage Scanning Electron Microscopy
Since the emergence of the COVID-19 pandemic in 2020, scientists and researchers worldwide have been grappling with the complexities of the virus's impact on...
Sanofi annuncia un accordo per un potenziale vaccino primo della sua classe contro l’E....
Parigi, 3 ottobre 2023 – In uno sviluppo significativo per la salute pubblica, Sanofi, leader globale nel settore sanitario, ha annunciato un accordo con Janssen...
Sanofi Announces Agreement for Potential First-in-Class Vaccine Against Extraintestinal Pathogenic E. coli
Paris, October 3, 2023 - In a significant development for public health, Sanofi, a global leader in healthcare, has announced an agreement with Janssen...
Ossido nitrico per inalazione ad alte dosi in COVID-19: uno studio completo
L'ossido nitrico (NO) per via inalatoria, un vasodilatatore polmonare selettivo, ha ottenuto l'approvazione della FDA nel 1999 per l'uso neonatale, in particolare per i...
High-Dose Inhaled Nitric Oxide in COVID-19: A Comprehensive Study
Inhaled nitric oxide (NO), a selective pulmonary vasodilator, gained FDA approval in 1999 for neonatal use, specifically for newborns with hypoxemic respiratory failure and...
L’incombente minaccia della resistenza antimicrobica (AMR) nel mezzo della pandemia: una panoramica completa
Mentre il mondo è alle prese con la continua ripresa dalla recente pandemia di COVID-19, è sorto un nuovo pericolo, che minaccia la salute...
The Looming Threat of Antimicrobial Resistance (AMR) Amidst the Pandemic: A Comprehensive Overview
As the world grapples with the ongoing recovery from the recent COVID-19 pandemic, a new peril has arisen, threatening human health, food security, and...
The Role of Small Non-Coding RNAs in SARS-CoV-2 Infection
The outbreak of pneumonia that originated in Wuhan, China, at the end of 2019 marked the beginning of a global public health crisis. This...
The Role of SARS-CoV-2 Protein NSP9 and MID1 in Cytokine Storm During COVID-19
COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in late 2019 and swiftly escalated into a global pandemic.
As of June...
